Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

2017554 citationsJournal Articlehybrid Open Access

Authors

Sudarshini Ramanathan · The University of Sydney

Shekeeb S. Mohammad · The University of Sydney

Esther Tantsis · The University of Sydney

Tina K. Nguyen · The University of Sydney

Vera Merheb · The University of Sydney

Victor S.C. Fung · The University of Sydney

Owen White ·

Abstract

Relapsing MOG antibody-associated demyelination is strongly associated with ON across all age groups and ADEM in children. Patients are highly responsive to steroids, but vulnerable to relapse on steroid reduction and cessation.

Topics & Keywords

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Systemic Lupus Erythematosus Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Neurology Neurosurgery & Psychiatry

Volume 89, Issue 2, pp. 127-137

DOI: 10.1136/jnnp-2017-316880

Field-Weighted Citation Impact: 34.88